OptiBiotix Health (OPTI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 15.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 33.00p
  • 52 Week Low: 10.25p
  • Currency: UK Pounds
  • Shares Issued: 97.94m
  • Volume: 87,108
  • Market Cap: £14.94m
  • Beta: 0.01

OptiBiotix launches SlimBiome products on Amazon India

By Josh White

Date: Monday 20 Jan 2025

LONDON (ShareCast) - (Sharecast News) - OptiBiotix Health announced the launch of multiple SlimBiome-containing products under its GoFigure brand on Amazon India on Monday, marking a strategic expansion into the country's rapidly growing weight management market.
The AIM-traded firm said the initiative was part of its broader multi-channel strategy aimed at increasing product sales through both online and in-store channels.

India, now the world's most populous nation, was projected to have the largest cohort of medium- to high-income consumers by 2035.

With obesity prevalence currently at 40.3%, the board said the market presented significant opportunities for weight management solutions.

OptiBiotix said its wholly-owned OptiBiotix India subsidiary would sell GoFigure products via Amazon, in addition to their existing presence in Apollo Pharmacies and on Apollo's e-commerce platform.

The launch on Amazon India coincided with a rebranding of the product's packaging and a relaunch in Apollo pharmacies.

OptiBiotix said the new design featured more vibrant colours to enhance visibility, and included prominent branding of Tata's Fossence, a locally-recognised ingredient aimed to enhance consumer trust and familiarity.

The GoFigure range is manufactured in India using local suppliers, incorporating Tata's proprietary Fossence prebiotic ingredient.

"Launching products on Amazon India is another step forward in building a presence for the Company's products in the strategically important Indian market," said chief executive officer Stephen O'Hara.

"We are now building SlimBiome's presence across India via our own brand products through Amazon India and via Apollo pharmacies, and as private label partnerships following the recent launch by Dr Morepen.

"This initial launch will include four products with subsequent launches taking place throughout 2025 dependent on sales progress."

At 1515 GMT, shares in OptiBiotix Health were up 5.41% at 17.92p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OPTI Market Data

Currency UK Pounds
Share Price 15.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 33.00p
52 Week Low 10.25p
Volume 87,108
Shares Issued 97.94m
Market Cap £14.94m
Beta 0.01

OPTI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
7.08% below the market average7.08% below the market average7.08% below the market average7.08% below the market average7.08% below the market average
58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average
Price Trend
10.60% above the market average10.60% above the market average10.60% above the market average10.60% above the market average10.60% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Income Not Available
Growth
81.25% below the market average81.25% below the market average81.25% below the market average81.25% below the market average81.25% below the market average
93.55% below the sector average93.55% below the sector average93.55% below the sector average93.55% below the sector average93.55% below the sector average

OPTI Dividends

No dividends found

Trades for 01-Apr-2025

Time Volume / Share Price
16:12 5,000 @ 15.22p
15:44 10,000 @ 15.22p
14:18 4,576 @ 15.22p
09:43 10,100 @ 15.25p
09:29 194 @ 15.50p

OPTI Key Personnel

CEO Stephen O'Hara
Finance Director David Blain

Top of Page